NOV Inc. Stock
The NOV Inc. stock is trending slightly upwards today, with an increase of €0.14 (0.920%) compared to yesterday's price.
Currently there is a rather positive sentiment for NOV Inc. with 13 Buy predictions and 3 Sell predictions.
With a target price of 24 € there is a hugely positive potential of 62.82% for NOV Inc. compared to the current price of 14.74 €.
Our community identified positive and negative aspects for NOV Inc. stock for the coming years. 1 users see the criterium "Balance Sheet Risk" as a plus for the NOV Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of NOV Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of NOV Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
NOV Inc. | 0.920% | 2.789% | -9.348% | -24.796% | -19.891% | 28.174% | -28.620% |
SBM Offshore N.V. | 1.600% | 1.693% | -2.171% | 22.693% | 29.140% | 6.746% | 2.270% |
Core Laboratories Inc. | - | 10.738% | -6.780% | -27.473% | 3.513% | -28.879% | -62.838% |
Cimc Enric Holdings Inc. | 0.770% | -0.758% | -16.026% | -19.136% | -17.089% | -41.518% | 17.869% |
Comments
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Morgan Stanley from $25.00 to $23.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at Barclays PLC from $17.00 to $20.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at TD Cowen from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for NOV provided by MarketBeat